option
Home
Flash News
Content
JustinLewis
JustinLewis
December 15, 2025

Biotech startup Chai Discovery raised 130 million dollars in a Series B round led by General Catalyst and Oak HCFT reaching a 13 billion dollar valuation The OpenAIbacked firm uses AI models for drug discovery aiming to de novo design antibodies and molecules with its latest Chai 2 system

Biotech startup Chai Discovery raised 130 million dollars in a Series B round led by General Catalyst and Oak HCFT reaching a 13 billion dollar valuation The OpenAIbacked firm uses AI models for drug discovery aiming to de novo design antibodies and molecules with its latest Chai 2 system
Comments (0)
0/300
OR